In addition, it has been shown that ELOVL4 promotes the differentiation and healthy accumulation of lipids in neuroblastoma cells but is transcriptionally regulated by the MYCN oncogene, which has severe implications on disease outcomes for neuroblastoma patients [62]. The gene discussed is ELOVL4; the disease is neuroblastoma.